Sentrx Animal Care, Inc. – Trademark Portfolio

Entity Type: 03

Sentrx Animal Care, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EPISANIS, OCULENIS, OCUNOVIS, and SENTRX ANIMAL CARE. The owner is based in Salt Lake City, UT.

570 West 1700 South, Suite # 1400

Salt Lake City, UT 84115

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Sentrx Animal Care, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Sentrx Animal Care, Inc. have?

Sentrx Animal Care, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 3 cancelled.

What trademark classes does Sentrx Animal Care, Inc. file in?

Sentrx Animal Care, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Sentrx Animal Care, Inc.'s most well-known trademarks?

Sentrx Animal Care, Inc.'s registered trademark portfolio includes well-known marks such as EPISANIS, OCULENIS, OCUNOVIS, and SENTRX ANIMAL CARE. These are among 4 currently registered trademarks in the portfolio.

What is Sentrx Animal Care, Inc.'s trademark registration success rate?

Sentrx Animal Care, Inc. has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.